Bone health and fracture risk during ADT for prostate cancer
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Bone health and fracture risk during ADT for prostate cancer
-
Narrated by:
-
By:
This episode is proudly brought to you by Aspen Pharmacare in the interest of education, awareness, and support. As we observe Men’s Health Month this June, we’re turning the spotlight on the unique challenges and triumphs men face on their cancer journey — encouraging a culture of openness and proactive health.
Dr Omondi Ogude is a medical oncologist serving as a director of the Sandton Oncology Medical Group and practices at the Sandton Oncology Centre. He specialises in breast, gastrointestinal, and gynaecological malignancies and is actively involved in research. He serves as a principal investigator and sub-investigator on multiple trials. He also chairs and sits on various multi-disciplinary forums in Johannesburg and advisory boards locally and internationally. Facebook · Twitter · Instagram · LinkedIn
adbl_web_anon_alc_button_suppression_t1
No reviews yet